Nanopath

Nanopath Inc

5 Investors
Molecular diagnostics
CAMBRIDGE, MA

Nanopath Inc is a pioneering molecular diagnostics company headquartered in Cambridge, Massachusetts. The company is dedicated to revolutionizing traditional medical testing approaches, particularly in the domain of women's health, by developing rapid and accurate diagnostic solutions.

Products & Team

Molecular Diagnostic Technology

Diagnostic technologySeed

Nanopath's molecular diagnostic technology offers rapid and comprehensive testing solutions designed specifically for women's health. This platform allows healthcare providers to obtain clinically actionable insights quickly, aiding in more prompt and accurate health assessments.

Value Proposition

The technology addresses the challenge of slow and often incomplete results associated with traditional diagnostic methods, thereby improving patient outcomes through faster and more reliable testing.

Pain Points

The need for quick, accurate diagnostics that fit within immediate office visits without compromising on the clarity or completeness of health information.

Rapid testing capabilitiesDetailed diagnostic resultsDesigned for use within a single office visit
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
CAMBRIDGE, MA
Primary headquarters

Funding History

Total Raised:
$5.3M
E

Debt Financing Offering

January 2025
$6.0M
Target
Progress
89%
Raised
$5.3M
Target
$6.0M
#000205447225000002